Get the Stockscreener App
8.64
0.12%
0.010
After Hours:
8.61
-0.03
-0.35%
Immunitybio Inc stock is traded at $8.64, with a volume of 8.94M.
It is up +0.12% in the last 24 hours and up +13.98% over the past month.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
See More
Previous Close:
$8.63
Open:
$8.5
24h Volume:
8.94M
Relative Volume:
0.86
Market Cap:
$9.16B
Revenue:
$140.98M
Net Income/Loss:
$-854.60M
P/E Ratio:
-10.12
EPS:
-0.854
Net Cash Flow:
$-299.31M
1W Performance:
+2.13%
1M Performance:
+13.98%
6M Performance:
+16.52%
1Y Performance:
+245.60%
1-Day Range:
$8.31
$8.675
1-Week Range:
$8.20
$9.48
52-Week Range:
$1.95
$12.43
Immunitybio Inc Stock (IBRX) Company Profile
Name
Immunitybio Inc
Sector
Industry
Phone
(844) 696-5235
Address
3530 JOHN HOPKINS COURT, SAN DIEGO
Compare IBRX vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
8.64 | 9.15B | 140.98M | -854.60M | -299.31M | -0.854 |
VRTX
Vertex Pharmaceuticals Inc
|
522.38 | 130.87B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
796.02 | 82.55B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
194.82 | 72.70B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
962.22 | 59.17B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
199.86 | 40.88B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Resumed | BTIG Research | Buy |
| May-20-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-06-25 | Initiated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | BTIG Research | Buy |
| May-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-03-22 | Initiated | Jefferies | Buy |
View All
Immunitybio Inc Stock (IBRX) Latest News
ImmunityBio’s New Bladder Cancer Combo Trial: What Investors Should Know - TipRanks
ImmunityBio, Inc. (26CA.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
ImmunityBio Advances Patient-Centric Clinical Trial Design in Bladder Cancer - Oncodaily
ImmunityBio, Inc. (IBRX) Stock Price, News, Quote & History - Yahoo! Finance Canada
IBRX Stock Slips Overnight: Insider Sale Tests Retail Optimism Ahead Of FDA Growth Catalyst - Stocktwits
$ImmunityBio (IBRX.US)$ - moomoo.com
ImmunityBio (IBRX) Meeting With Turkish President Fuels Expansion Hopes, Shares Climb 10% - Insider Monkey
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Euro Price Today | Live IBRX to EUR Converter & Exchange Rate - CryptoRank
ImmunityBio Confirms Trial Strength For Anktiva In Bladder Cancer - Stocktwits
Could IBRX Be A Tokenized Stock? Founder’s Tease Sends ImmunityBio Traders Into Speculation Mode - Stocktwits
ImmunityBio Inc. (IBRX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ImmunityBio, Inc. (IBRX) And Encourages Shareholders to Reach Out - ACCESS Newswire
IBRX Stock Climbs Overnight: ImmunityBio Declares ‘All Systems Go’ For Dunkirk Anktiva Manufacturing Push - Stocktwits
ImmunityBio (IBRX) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance
ImmunityBio (IBRX) Draws Fresh Attention, Is The Stock Still Undervalued? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
ImmunityBio, Inc. (IBRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
SLS, IBRX Stocks Draw Investor Attention With Major Cancer Conferences And New Drug Data On Deck - Yahoo Finance
IBRX Stock In Spotlight As FDA Scrutiny Prompts ImmunityBio To Withdraw Content, Tighten Oversight - Stocktwits
IBRX Stock Eyes Worst Week Since July: New Patent Eyes Broader Anktiva Use Ahead Of Lung Cancer Conference - Stocktwits
Bronstein, Gewirtz & Grossman, LLC Is Investigating ImmunityBio, Inc. (IBRX) And Encourages Investors to Connect - ACCESS Newswire
U.S. Presidential Envoy Joins Albania’s Religious Leaders to Honor Mother Teresa as Bektashi Order Announces Signed American Cancer-Care Partnership - albaniandailynews.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ImmunityBio, Inc. Tokenized Stock (Robinhood) to British Pound Sterling Price Today | Live IBRX to GBP Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Japanese Yen Price Today | Live IBRX to JPY Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Indonesian Rupiah Price Today | Live IBRX to IDR Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Chinese Yuan Price Today | Live IBRX to CNY Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to South Korean Won Price Today | Live IBRX to KRW Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Canadian Dollar Price Today | Live IBRX to CAD Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to United States Dollar Price Today | Live IBRX to USD Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Vietnamese Dong Price Today | Live IBRX to VND Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Indian Rupee Price Today | Live IBRX to INR Converter & Exchange Rate - CryptoRank
ImmunityBio Founder Pushes Back After FDA Warning Letter Over Anktiva Claims — Says Ad 'Never Aired At All' - Stocktwits
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Investors to Learn More About the Investigation | NDAQ:IBRX | Press Release - Stockhouse
IBRX Stock Jumps Overnight: UAE Grants Anktiva Broadest Approval Yet After Founder’s ‘July Birthday News’ Tease - Stocktwits
IBRX Stock Slips Overnight: Founder Teases Turkey Push, Says AI Cancer Cell Robot Is ‘Almost There’ - Stocktwits
IBRX|Immunitybio Inc|Price:8.080|Chg%:-0.110 - TradingKey
Historical Data for ImmunityBio, Inc. Tokenized Stock (Robinhood) in USD - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) Exchanges IBRX Markets | Buy & Sell & Trade - CryptoRank
Why Is ImmunityBio (IBRX) Up 9.7% Since Last Earnings Report? - Yahoo Finance
ImmunityBio: None Of The Moonshots Is Priced In (NASDAQ:IBRX) - Seeking Alpha
IBRX to IDR: ImmunityBio, Inc. • Robinhood Token Price in Indonesian Rupiah - CoinGecko
Bronstein, Gewirtz & Grossman, LLC Is Investigating ImmunityBio, Inc. (IBRX) And Encourages Stockholders to Connect - ACCESS Newswire
IBRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
ImmunityBio, Inc. (IBRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ImmunityBio, Inc. Tokenized Stock (Robinhood) Closing Price (USD)Quarterly - CryptoRank
ImmunityBio Stock Short Interest Falls to 31.8% - Quiver Quantitative
ImmunityBio: ANKTIVA Is Real, The Valuation Isn't (NASDAQ:IBRX) - Seeking Alpha
Does ImmunityBio’s (IBRX) Jim Yong Kim Hire Transform Its Global Access Strategy For Immunotherapies? - simplywall.st
ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitContact Kessler Topaz Meltzer & Check, LLP - Morningstar
IBRX Stock Eyes Best Week Since February: Founder Highlights New Anktiva-NK Cell Therapy Study - Stocktwits
Immunitybio Inc Stock (IBRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
1.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):